American Journal of Cardiology
Volume 102, Issue 9 , Pages 1125-1130 , 1 November 2008

Differential Impact of Admission C-Reactive Protein Levels on 28-Day Mortality Risk in Patients With ST-Elevation Versus Non–ST-Elevation Myocardial Infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry)

  • Bernhard Kuch, MD

      Affiliations

    • I. Medizinische Klinik, Hospital of Augsburg, Teaching Hospital of the Ludwig Maximilians University München, Augsburg, Germany
    • Corresponding Author InformationCorresponding author: Tel: +49-821-400-2956; fax: +49-821-400-3345
    • ,
  • Wolfgang von Scheidt, MD

      Affiliations

    • I. Medizinische Klinik, Hospital of Augsburg, Teaching Hospital of the Ludwig Maximilians University München, Augsburg, Germany
    • ,
  • Birgitt Kling, MD

      Affiliations

    • I. Medizinische Klinik, Hospital of Augsburg, Teaching Hospital of the Ludwig Maximilians University München, Augsburg, Germany
    • ,
  • Margit Heier, MD

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
    • Hospital of Augsburg, MONICA/KORA Myocardial Infarction Registry, Augsburg, Germany
    • ,
  • Allmut Hoermann, MSc

      Affiliations

    • Institute of Health Economics, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
    • ,
  • Christa Meisinger, MD, MPH

      Affiliations

    • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
    • Hospital of Augsburg, MONICA/KORA Myocardial Infarction Registry, Augsburg, Germany

Received 5 May 2008 ,Revised 9 June 2008 ,Accepted 9 June 2008.

References 

  1. Toss H, Lindahl B, Siegbahn A, Wallentin L The FRagmin during InStability in Coronary artery disease (FRISC) Study Group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 1997;96:4204–4210
  2. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L The FRagmin during InStability in Coronary artery disease (FRISC) Study Group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000;343:1139–1147
  3. Heeschen C, Hamm CW, Bruemmer J, Simoons ML The Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment (CAPTURE) Investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. J Am Coll Cardiol. 2000;35:1535–1542
  4. WHO MONICA Project Principal Investigators. World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol. 1988;41:105–114
  5. Kuch B, Bolte HD, Hörmann A, Meisinger C, Löwel H. What is the real hospital mortality from acute myocardial infarction? (Epidemiological vs. clinical view). Eur Heart J. 2002;23:714–720
  6. Meisinger C, Hörmann A, Heier M, Kuch B, Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol. 2006;113:229–235
  7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  8. Kuch B, von Scheidt W, Kling B, Heier M, Hörmann A, Meisinger C. Characteristics and outcome of patients with acute myocardial infarction according to presenting electrocardiogram (from the MONICA/KORA Augsburg Myocardial Infarction Registry). Am J Cardiol. 2007;100:1056–1060
  9. Rebuzzi AG, Quaranta G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR, et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol. 1998;82:715–719
  10. Tomoda H, Aoki N. Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J. 2000;140:324–328
  11. de Winter RJ, Heyde GS, Koch KT, Fischer J, van Straalen JP, Bax M, et al. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J. 2002;23:960–966
  12. Sanchez PL, Palacios IF, Pobon P, Santos I, Rodriguez MV, Villacorta E, et al. Relationship between C-reactive protein and the electrocardiographic pattern on admission in patients with acute coronary syndrome. Cardiology. 2005;104:45–50
  13. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB The European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462–466
  14. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36–44
  15. Moghbeli N, Kirtane AJ, Ray KK, Murphy SA, Gibson CM, Braunwald E, et al. C-Reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial). Am J Cardiol. 2005;96:635–638
  16. Ridker PM, Buring JE, Cook NR, Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391–397
  17. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary disease: the FRISC Study Group. Circulation. 1996;93:1651–1657
  18. Ohman E, Armstrong P, Christenson R, Granger CB, Katus HA, Hamm CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333–1341
  19. Hamm C, Ravkilde J, Gerhardt W, Jørgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146–150
  20. Foussas SG, Zairis MN, Makrygiannis SS, Manousakis SJ, Anastassiadis FA, Apostolatos CS, et al The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction. Heart. 2007;93:952–956
  21. Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, et al. Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction. Crit Care Med. 2002;30:2229–2235
  22. Giannitsis E, Müller-Bardorff M, Lehrke S, Wiegand U, Tölg R, Weidtmann B, et al. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction. Circulation. 2001;104:630–635
  23. James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome. J Am Coll Cardiol. 2003;41:916–924
  24. Celik T, Iyisoy A, Kursaklioglu H, Turhan H, Kilic S, Kose S, et al. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Coron Artery Dis. 2005;16:293–299
  25. Zairis MN, Manousakis SJ, Stefanidis AS, Papadaki OA, Andrikopoulos GK, Olympios CD, et al. C-Reactive protein levels on admission are associated with response to thrombolytic and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J. 2002;144:782–789
  26. Canale ML, Stroppa S, Caravelli P, Petronio AS, Mariotti R, Mariani M, et al. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation. Coron Artery Dis. 2006;17:693–698
  27. Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart. 2002;87:201–204
  28. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyoid A protein in severe unstable angina. N Engl J Med. 1994;331:417–424
  29. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, et al. C-Reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation. 1999;100:96–102
  30. De Servi S, Mariani M, Mariani G, Mazzone A. C-Reactive protein increase in unstable coronary disease: cause or effect?. J Am Coll Cardiol. 2005;46:1496–1502

 The Cooperative Health Research in the Region of Augsburg (KORA) research platform and the Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA) Augsburg studies were initiated and supported by the Helmholtz Zentrum München, Germany, German Research Center for Environmental Health, which is supported by the German Federal Ministry of Education, Science, Research and Technology and the State of Bavaria, München, Germany. Since 2000, myocardial infarction data collection is cofinanced by the German Federal Ministry of Health and Social Security, Berlin, Germany (www.gbe-bund.de).

PII: S0002-9149(08)01136-3

doi: 10.1016/j.amjcard.2008.06.034

American Journal of Cardiology
Volume 102, Issue 9 , Pages 1125-1130 , 1 November 2008

Article Tools

* Image Usage & Resolution